1. Real World Experience in the Era of First Generation Protease Inhibitors in the Treatment of Hepatitis C

   • Hope Hubbard
   • Eric Lawitz

   Hepatitis C: Therapeutics (MP Manns and T von Hahn, Section editors) 06 October 2013 Pages: 189 - 194

2. Relevance of Resistance Against Direct Acting Antiviral Agents in Hepatitis C Virus Infection – What Technology do we Really Need in Clinical Practice?

   • Sandra Ciesek
   • Thomas von Hahn

   Hepatitis C: Therapeutics (MP Manns and T von Hahn, Section editors) 21 September 2013 Pages: 195 - 199

3. Opportunities and Risks of Host-targeting Antiviral Strategies for Hepatitis C

   • Gisa Gerold
   • Thomas Pietschmann

   Hepatitis C: Therapeutics (MP Manns and T von Hahn, Section editors) 04 October 2013 Pages: 200 - 213

   

4. All Oral HCV Therapies of the Future

   • Sonal Kumar
   • Ira Jacobson

   Hepatitis C: Therapeutics (MP Manns and T von Hahn, Section editors) 05 November 2013 Pages: 214 - 219

5. The Role of Public Health in an Era of All-Oral Therapy for Hepatitis C Infection

   • John W. Ward

   Hepatitis C: Therapeutics (MP Manns and T von Hahn, Section editors) 10 October 2013 Pages: 220 - 226

   

6. Prevention and Treatment of Recurrent Hepatitis C after Liver Transplantation

   • Jennifer C. Price

   Hepatitis C: Therapeutics (MP Manns and T von Hahn, Section Editors) 05 November 2013 Pages: 227 - 235

7. Treatment of Hepatitis C in the Patient with Decompensated Cirrhosis

   • Gregory T. Everson
   • Asmeen Bhatt

   Hepatitis C: Therapeutics (MP Manns and T von Hahn, Section editors) 08 September 2013 Pages: 236 - 245

   

8. Treatment of Chronic Hepatitis C, Genotype 4

   • Peter Ferenci

   Hepatitis C: Therapeutics (MP Manns and T von Hahn, Section editors) 24 August 2013 Pages: 246 - 250

9. Natural History of HCV-induced Liver Disease

   • Adriaan J. van der Meer
   • Raoel Maan
   • Bart J. Veldt

   Hepatitis C: Therapeutics (MP Manns and T von Hahn, Section Editors) 05 November 2013 Pages: 251 - 260

   

10. Current and Future Treatment of Chronic Hepatitis C Genotype 2 and 3

    • Christoph Hoener zu Siederdissen
    • Markus Cornberg

    Hepatitis C: Therapeutics (MP Manns and T von Hahn, Section editors) 09 October 2013 Pages: 261 - 268

    

11. Treatment of Hepatitis C in HIV Patients in the New Era of Direct-Acting Antivirals

    • José Vicente Fernández-Montero
    • Eugenia Vispo
    • Vincent Soriano

    Global Perspectives: South America (MO Silva, Section editor) 30 August 2013 Pages: 269 - 275

    

12. IL28B Polymorphisms Among Latin American HCV Patients

    • Alejandro Soza
    • Marcelo Lopez-Lastra

    Global Perspectives: South America (MO Silva, Section editor) 31 August 2013 Pages: 276 - 279

    

13. Limited Access to Protease Inhibitors Therapy for Chronic HCV in the Region: YES

    • Julio Castro Méndez
    • Lucy Dagher

    Global Perspectives: South America (MO Silva, Section editor) 13 September 2013 Pages: 280 - 287

14. Is There a Need for Cluster Hepatitis B and C Epidemiological Studies in the Region?: Yes

    • Jorge T. Insua

    Global Perspectives: South America (MO Silva, Section editor) 12 October 2013 Pages: 288 - 296

    

15. New Insights in the Diagnosis, Pathogenesis and Treatment of Hepatitis B- and C-related Hepatocellular Carcinoma

    • Nancy Aguilar-Olivos
    • Sofía Ornelas-Arroyo
    • Nahum Méndez-Sánchez

    Global Perspectives: South America (MO Silva, Section Editor) 13 October 2013 Pages: 297 - 304

    

16. Implementation and Impact of HAV and HBV Vaccination Programs in South America

    • Raymundo Paraná
    • Maria Isabel Schinoni

    Global Perspectives: South America (MO Silva, Section Editor) 26 September 2013 Pages: 305 - 311

17. Update on HIV and Hepatitis Virus Coinfection: The South American Perspective

    • H. Fainboim
    • M. Dirchwolf

    Global Perspectives: South America (MO Silva, Section Editor) 15 October 2013 Pages: 312 - 319